|
OSGEPL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.454090E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.255790E-01 |
| Normal-vs-Stage2 |
5.630000E-02 |
| Normal-vs-Stage3 |
4.914000E-01 |
| Normal-vs-Stage4 |
1.279390E-01 |
| Stage1-vs-Stage2 |
1.964410E-01 |
| Stage1-vs-Stage3 |
9.511200E-01 |
| Stage1-vs-Stage4 |
1.328790E-01 |
| Stage2-vs-Stage3 |
4.324400E-01 |
| Stage2-vs-Stage4 |
6.737000E-01 |
| Stage3-vs-Stage4 |
3.459600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.389770E-02 |
| Normal-vs-AfricanAmerican |
1.651590E-01 |
| Normal-vs-Asian |
5.686000E-01 |
| Caucasian-vs-AfricanAmerican |
7.322200E-01 |
| Caucasian-vs-Asian |
9.310800E-01 |
| AfricanAmerican-vs-Asian |
8.374400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.001900E-02 |
| Normal-vs-Female |
1.039520E-02 |
| Male-vs-Female |
1.203030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.860780E-01 |
| Normal-vs-Extreme_Weight |
4.526600E-01 |
| Normal-vs-Obese |
1.655220E-01 |
| Normal-vs-Extreme_Obese |
2.053200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.132600E-01 |
| Normal_Weight-vs-Obese |
7.083200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.119800E-01 |
| Extreme_Weight-vs-Obese |
5.408000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.807600E-01 |
| Obese-vs-Extreme_Obese |
4.368400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.953500E-02 |
| Normal-vs-Age(41-60Yrs) |
2.382500E-03 |
| Normal-vs-Age(61-80Yrs) |
3.866200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.776800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.899820E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.664010E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.872050E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.060200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.503200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.970800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.703300E-03 |
| Normal-VS-Type2 PRCC |
3.779600E-01 |
| Normal-VS-KIRP CIMP |
6.914600E-01 |
| Normal-VS-Unclassified PRCC |
1.049550E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.000600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.091000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.115000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.976200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.614200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.380400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.782800E-01 |
| Normal-vs-N1 |
1.191200E-01 |
| Normal-vs-N2 |
7.158400E-01 |
| N0-vs-N1 |
2.771600E-01 |
| N0-vs-N2 |
9.830200E-01 |
| N1-vs-N2 |
6.519800E-01 |
|
|
